Stay updated with breaking news from க்ஸிற். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CSIR-IICT, Lee Pharma in licensing agreement for synthesis of 2-DG CSIR-IICT, Lee Pharma in licensing agreement for synthesis of 2-DG 09 June 2021 | News Lee Pharma will manufacture and commercialise the 2-DG sachets from their formulation facility located at SEZ, Duvvada www.shutterstock.com shIndian Institute of Chemical Technology, (IICT), a constituent laboratory of CSIR and Lee Pharma, an integrated pharmaceutical company, based in Hyderabad have entered into a non-exclusive licensing agreement for the synthesis of 2-Deoxy-D-Glucose (2-DG). Recently, 2-DG developed by DRDO and Dr Reddy’s Laboratories has received approval for use in COVID-19 patients. It has been found to help speed up recovery and reduce oxygen dependence and Dr Reddy’s Laboratories has launched the drug in the form of sachets. ....
CSIR Begins Phase-II Trial For Using Niclosamide - A Drug To Treat Tapeworm Infection As Covid-19 Remedy swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.